注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶？ 登入
解鎖優質數據: 高達 50%折扣優惠 InvestingPro 獲取優惠
Fidelity Select Pharmaceuticals Port
29.79
+0.41
+1.40%
FPHAX綜觀
你可在本頁找到深入的Fidelity Select Pharmaceuticals Portfolio公司檔案，包括FPHAX的主要管理層、總資產、投資策略及聯絡資料，以及各類其他資訊。
聯絡資訊
地址
483 Bay Street
Toronto,ON M5G 2N7
Canada
Toronto,ON M5G 2N7
Canada
電話
416-307-5200
傳真
1-800-387-8092
主要管理層
| 名稱 | 主旨 | 成立於 | 直至 |
|---|---|---|---|
| Karim Suwwan de Felipe | Research Analyst/Portfolio Manager | 2017 | now |
| 自傳 | Karim Suwwan de Felipe is a research analyst and portfolio manager in the Equity division at Fidelity Investments. Fidelity Investments is a leading provider of investment management, retirement planning, portfolio guidance, brokerage, benefits outsourcing, and other financial products and services to institutions, financial intermediaries, and individuals. In this role, Mr. Suwwan de Felipe is responsible for covering and providing recommendations on stocks in the global pharmaceutical sector. Additionally, he manages the Fidelity Select Pharmaceuticals Portfolio. Prior to joining Fidelity in 2010, Mr. Suwwan de Felipe was a senior research associate at Citi Investment Research and Analysis. As a member of the biotechnology research team at Citi, he helped formulate recommendations on large and mid-cap biotechnology equities. Previously, Mr. Suwwan de Felipe conducted molecular biology research at CuraGen Corporation, a biotechnology company in Connecticut, and at Yale University’s Department of Therapeutic Radiology. Mr. Suwwan de Felipe earned his bachelor of science degree in molecular biophysics and biochemistry from Yale University, and his doctorate degree with distinction in cellular, molecular, and biophysical studies from Columbia University’s College of Physicians and Surgeons. | ||
| Asher Anolic | Portfolio Manager | 2013 | 2018 |
| 自傳 | Asher Anolic is co-manager of the VIP Growth Portfolio, which he has managed since July 2017. He also manages other funds. Since joining Fidelity Investments in 2008, Mr. Anolic has worked as a research analyst and portfolio manager. Prior to joining Fidelity Investments in 2008, Mr. Anolic worked for Bear Stearns as a research analyst. | ||
| Andrew Oh | Equity Research Analyst | 2006 | 2013 |
| 自傳 | Oh joined Fidelity Investments in 2006 as an equity research analyst. Prior to Fidelity, he was director and senior pharmaceuticals analyst for Leernik Swann & Company in New York. From 2001 to 2004, he was senior equity research associate following the U.S. large cap pharmaceuticals sector for JP Morgan Chase in New York. | ||
| Harlan P. Carere | Portfolio Manager | 2005 | 2007 |
| 自傳 | Carere is a portfolio manager of Fidelity Investments. He joined Fidelity International Limited in London in 2000 as an equity research analyst following the technology sector. He subsequently served as technology sector leader in the London office. Prior to joining the firm, he was an equity analyst for Berman Capital. | ||
| Ian Gutterman | Portfolio Manager | 2005 | 2005 |
| 自傳 | Gutterman is a portfolio manager with Fidelity Investments, his employer since 1999. Prior to joining the firm, he was a treasury analyst with MT Bank from 1995 to 1997. | ||
| Gavin Baker | Sector Leader | 2002 | 2005 |
| 自傳 | Baker joined Fidelity in 1999 as an equity research analyst following companies in the cement and building materials industries. He subsequently followed the semiconductor industry. In 2002, Baker began following the pharmaceutical sector, and managed Fidelity Select Pharmaceuticals Portfolio from 2002 to 2005. He then started following large- cap consumer stocks before assuming — in 2006 —the role of diversified analyst working with the large– cap growth group. Baker most recently began serving as sector leader of the telecom and utilities equity research group. | ||
| Yolanda S. Strock | equity analyst/portfolio Manager | 2001 | 2002 |
| 自傳 | Yolanda Strock joined Fidelity in 1997 where she is the sector leader of the Health Care Equity Resesarch group. She began managing Fidelity Select Biotechnology Portfolio in February 2000, and assumed her other fund management responsibilities and role of sector leader in June 2000. Yolanda has an MBA in Finance from the Fuqua School of Business at Duke University, a BSc in Marketing from the Wharton School of Business and a BA in economics from the University of Pennsylvania. | ||
在留言中加插圖表
確認封鎖
你確定要封鎖 %USER_NAME%？
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖，必須等候 48 小時後才可再次封鎖。
舉報此評論
我覺得這個評論是:
評論被加標記
謝謝！
您的報告已被發送到我們的版主審核